Genotoxicity of Escherichia coli Nissle 1917 strain cannot be dissociated from its probiotic activity
Open Access
- 16 November 2012
- journal article
- research article
- Published by Taylor & Francis Ltd in Gut Microbes
- Vol. 3 (6), 501-509
- https://doi.org/10.4161/gmic.21737
Abstract
Oral administration of the probiotic bacterium Escherichia coli Nissle 1917 improves chronic inflammatory bowel diseases, but the molecular basis for this therapeutic efficacy is unknown. E. coli Nissle 1917 harbors a cluster of genes coding for the biosynthesis of hybrid nonribosomal peptide-polyketide(s). This biosynthetic pathway confers the ability for bacteria to induce DNA double strand breaks in eukaryotic cells. Here we reveal that inactivation of the clbA gene within this genomic island abrogated the ability for the strain to induce DNA damage and chromosomal abnormalities in non-transformed cultured rat intestinal epithelial cells but is required for the probiotic activity of E. coli Nissle 1917. Thus, evaluation of colitis severity induced in rodent fed with E. coli Nissle 1917 or an isogenic non-genotoxic mutant demonstrated the need for a functional biosynthetic pathway both in the amelioration of the disease and in the modulation of cytokine expression. Feeding rodents with a complemented strain for which genotoxicity was restored confirmed that this biosynthetic pathway contributes to the health benefits of the probiotic by modulating its immunomodulatory properties. Our data provide additional evidence for the benefit of this currently used probiotic in colitis but remind us that an efficient probiotic may also have side effects as any other medication.Keywords
This publication has 39 references indexed in Scilit:
- Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanismJCI Insight, 2011
- Safety assessment of probiotics for human useGut Microbes, 2010
- Probiotics: progress toward novel therapies for intestinal diseasesCurrent Opinion in Gastroenterology, 2010
- Dextran sulfate sodium and 2,4,6-trinitrobenzene sulfonic acid induce lipid peroxidation by the proliferation of intestinal gram-negative bacteria in miceJournal of Inflammation, 2010
- A microbial symbiosis factor prevents intestinal inflammatory diseaseNature, 2008
- Probiotic Escherichia coli Nissle 1917 Inhibits Leaky Gut by Enhancing Mucosal IntegrityPLOS ONE, 2007
- Dual-association of gnotobiotic Il-10−/− mice with 2 nonpathogenic commensal bacteria induces aggressive pancolitisInflammatory Bowel Diseases, 2007
- Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazineGut, 2004
- Analysis of the Genome Structure of the Nonpathogenic Probiotic Escherichia coli Strain Nissle 1917Journal of Bacteriology, 2004
- Double‐blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitisAlimentary Pharmacology & Therapeutics, 1997